A study published in Stem Cell Reports demonstrates that genetically engineered human pluripotent stem cells (hPSCs) can ...

An Idaho Senate committee debated if the government should take a stronger role in labeling products developed using fetal ...

GLP-1 drugs have come to be thought of as “wonder drugs,” yet the mechanisms behind their many new health benefits have ...

A new study shows that ultramarathons damage and replenish red blood cells in ways that could help treat cancer patients.

Severe storms with damaging winds and possible tornadoes reach Houston early on Wednesday. Here's the latest timeline for when storms move through.

Novartis has settled a lawsuit by the estate of Henrietta Lacks that alleged the pharmaceutical giant unjustly profited off her cells.

The family of Henrietta Lacks, a woman whose cells were taken without her consent in 1951 and led to various medical advancements, has reached a settlement with pharmaceutical company Novartis for ...

TOPCon's global manufacturing expansion is creating an opportunity to rethink technology platforms and prepare for next-generation tandem architectures.

SRM Institute licenses its innovative cell encapsulation technology to Anabond, securing ₹1 crore upfront and future royalties.

CAR T-cell immunotherapy improved progression-free and overall survival in patients with relapsed or refractory marginal zone ...

GLP-1s are building a reputation as "wonder drugs." First characterized for their ability to improve insulin release and ...

Trilaciclib protects bone marrow before SCLC chemotherapy, sharply reducing neutropenia, anemia, and thrombocytopenia, improving fatigue and keeping treatment on schedule without weakening tumor kill.